(Q50997346)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792709%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792709%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792709%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Angélique Gougelet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792709%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Cécile Godard

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792709%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Carmen Marchiol

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792709%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Gilles Renault

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792709%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

10

Benoit Terris

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792709%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

11

Christine Perret

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792709%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

2

Chiara Sartor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792709%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

3

Laura Bachelot

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792709%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Frédéric Tores

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792709%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Patrick Nitschke

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792709%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Catherine Cavard

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792709%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

English

0 references

publication date

19 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792709%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792709%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792709%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792709%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

1024-1034

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792709%20AND%20SRC:MED&resulttype=core&format=json

The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapy

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

Apc tumor suppressor gene is the "zonation-keeper" of mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

microRNA: new diagnostic and therapeutic tools in liver disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

miR-221 overexpression contributes to liver tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

Protocol for the fast chromatin immunoprecipitation (ChIP) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

Epigenetic regulation of miR-34a expression in alcoholic liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

Expression of hepatic transcription factors during liver development and oval cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

A microRNA component of the p53 tumour suppressor network

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

Hepatocyte-specific deletion of hepatocyte nuclear factor-4α in adult mice results in increased hepatocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

MicroRNA-feedback loop as a key modulator of liver tumorigenesis and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

The transforming growth factor-α and cyclin D1 genes are direct targets of β-catenin signaling in hepatocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969

T-cell factor 4 and β-catenin chromatin occupancies pattern zonal liver metabolism in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308969